Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Orchestrated Customer Engagement

This white paper defines, describes, and documents the journey Life Sciences organizations may take to move from MCM and OCM to OCE.

Read More »

CME that Counts for ABIM MOC

Join our webinar on October 14 from 10:00 am–11:30 am Central to find out more about the Accreditation Council for CME (ACCME®) and American Board of Internal Medicine (ABIM) collaboration to simplify the integration of Maintenance of Certification (MOC) and accredited CME. We’ll answer your questions about registering CME activities for ABIM’s MOC program in […]

Read More »

The Integrated QC Micro Lab and Data Integrity

Lonza to Host Free Webinar on Integrated QC Processes and Data Integrity   Walkersville, MD, USA / Cologne, Germany, 16 October 2015 – Lonza has announced that it will host a free 60-minute webinar on 3 November 2015 titled “The Integrated QC Micro Lab and Data Integrity.” It will provide details about how laboratory professionals […]

Read More »

Technology Enabling Pharma Sales Force in Transforming Practice of Medicine to Science of Medicine

Mobile technology can give Pharmaceutical companies the boost it needs to improve marketing effective­ness and sales performance.

Read More »

FDA eye drug rebuff adds to Shire’s woes in Baxalta pursuit

Shire Plc suffered a setback for its most important pipeline medicine late on Friday, adding to the group’s problems as it pursues Baxalta Inc to forge the leading global specialist in rare diseases. The Irish company said the U.S. Food and Drug Administration (FDA) had declined to approve its new eye drug lifitegrast and had […]

Read More »

Early smoke exposure tied to increased atrial fibrillation risk

People exposed to secondhand smoke in the womb or as children are at an increased risk later in life for an irregular heart rhythm known as atrial fibrillation, a new study suggests.   “We can’t say that secondhand smoke definitely caused atrial fibrillation” based on this type of study, said senior author Dr. Gregory Marcus […]

Read More »

FDA Approves Praxbind (idarucizumab), Specific Reversal Agent for Pradaxa (dabigatran etexilate mesylate)

RIDGEFIELD, Conn., Oct. 16, 2015 /PRNewswire/ — Boehringer Ingelheim Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration (FDA) granted approval of Praxbind® (idarucizumab). PRAXBIND is indicated for patients treated with Pradaxa® (dabigatran etexilate mesylate), when reversal of the anticoagulant effects of dabigatran is needed for emergency surgery/urgent procedures or in life-threatening or uncontrolled bleeding. […]

Read More »

Daiichi Sankyo Inc. Reorganizes its U.S. Commercial Operations to Support Upcoming Specialty Pipeline

PARSIPPANY, N.J., Oct. 16, 2015 /PRNewswire/ — Daiichi Sankyo, Inc. (“the Company”) announced today that it will reorganize its U.S. Commercial organization as it begins to transition from a maturing primary care product portfolio to a differentiated specialty portfolio that will include areas such as cardiovascular, pain management and oncology.  “As we face the loss […]

Read More »

Nestle raises its bet on potential $10 billion health business

Nestle, famous for its coffee and chocolate, is stepping up investment in nutritional therapy, a business it believes will eventually generate annual sales of 10 billion Swiss francs ($10.5 billion).   Greg Behar, chief executive of Nestle Health Science, told Reuters that the unit formed in 2011 already had revenue of more than 2 billion […]

Read More »

Cempra’s experimental antibiotic succeeds in late-stage study

Cempra Inc moved a step closer to approval of its lead antibiotic after the potential blockbuster was successful in a second late-stage trial in patients with a common bacterial infection. Data announced in January had showed that the oral version of the drug was successful in a separate late-stage study in patients with community-acquired bacterial […]

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

April 2019 Focus: Healthcare agency & network profiles, industry overview & awards, and more!


Ad Right Bottom